| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |